ASHLEY CROW: Open Payments
NPI 1184123002 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 16 payments from 7 companies in 2025. Trend: 2023 $234 · 2024 $530 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $136 |
| Neurocrine BioSciences, Inc. | 6 | $111 |
| Teva Pharmaceuticals USA, Inc. | 3 | $80 |
| Novo Nordisk Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: VRAYLAR, INGREZZA, AUSTEDO XR, Auvelity, ZEPBOUND, SPRAVATO.
Industry payments across AR — which companies pay providers there.
